alexa Where is the Evidence? A Critical Review of Bias in the
ISSN: 2155-9627

Journal of Clinical Research & Bioethics
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article

Where is the Evidence? A Critical Review of Bias in the Reporting of Clinical Data for Exparel: A Liposomal Bupivacaine Formulation

Rita M. Hadley1 and Alan P Dine2*
1Advanced Surgical Partners, Springboro, OH, USA
2BSN, Kimberly Clark Corporation, Pleasant Plain, OH, USA
Corresponding Author : Alan P Dine
BSN, Kimberly Clark Corporation
Pleasant Plain, OH United States
Tel: 513-253-8033
Fax: 513-672-0181
E-mail: [email protected]
Received April 16, 2014; Accepted July 26, 2014; Published July 28, 2014
Citation: Hadley RM, Dine AP (2014) Where is the Evidence? A Critical Review of Bias in the Reporting of Clinical Data for Exparel: A Liposomal Bupivacaine Formulation. J Clinic Res Bioeth 5:189. doi:10.4172/2155-9627.1000189
Copyright: © 2014 Hadley RM, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
 

Abstract

Healthcare policies are formed through the dissemination of clinical information or evidence of effectiveness, so that this evidence can reach clinical practice. Manipulation or 'influence' over the data and the subsequent reporting of data can be introduced by anyone involved in a study. This may affect the perception of the evidence that becomes the basis for the determination of best practice in the care for our patients so it must be free of bias. This report illustrates an example of bias introduction into the clinical evidence portfolio of the recently introduced liposomal encapsulated bupivacaine Exparel™. This review then uses this new drug as an example of how bias is introduced into the clinical decision tree and its potential effect on the practice of medicine.

Keywords

Share This Page

Additional Info

Loading
Loading Please wait..
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords